321 related articles for article (PubMed ID: 17460077)
21. Missense Genetic Polymorphisms of Microsomal (
Can Demirdöğen B; Miçooğulları Y; Türkanoğlu Özçelik A; Adalı O
Neuropsychiatr Dis Treat; 2020; 16():3251-3265. PubMed ID: 33994786
[TBL] [Abstract][Full Text] [Related]
22. Epoxyeicosatrienoic acids enhance axonal growth in primary sensory and cortical neuronal cell cultures.
Abdu E; Bruun DA; Yang D; Yang J; Inceoglu B; Hammock BD; Alkayed NJ; Lein PJ
J Neurochem; 2011 May; 117(4):632-42. PubMed ID: 21155804
[TBL] [Abstract][Full Text] [Related]
23. Attenuation of cisplatin-induced renal injury by inhibition of soluble epoxide hydrolase involves nuclear factor κB signaling.
Liu Y; Webb HK; Fukushima H; Micheli J; Markova S; Olson JL; Kroetz DL
J Pharmacol Exp Ther; 2012 Jun; 341(3):725-34. PubMed ID: 22414856
[TBL] [Abstract][Full Text] [Related]
24. 14,15-Epoxyeicosatrienoic Acid Alleviates Pathology in a Mouse Model of Alzheimer's Disease.
Chen W; Wang M; Zhu M; Xiong W; Qin X; Zhu X
J Neurosci; 2020 Oct; 40(42):8188-8203. PubMed ID: 32973044
[TBL] [Abstract][Full Text] [Related]
25. Role of soluble epoxide hydrolase in age-related vascular cognitive decline.
Nelson JW; Young JM; Borkar RN; Woltjer RL; Quinn JF; Silbert LC; Grafe MR; Alkayed NJ
Prostaglandins Other Lipid Mediat; 2014 Oct; 113-115():30-7. PubMed ID: 25277097
[TBL] [Abstract][Full Text] [Related]
26. Soluble epoxide hydrolase: gene structure, expression and deletion.
Harris TR; Hammock BD
Gene; 2013 Sep; 526(2):61-74. PubMed ID: 23701967
[TBL] [Abstract][Full Text] [Related]
27. Protection of salvianolic acid A on rat brain from ischemic damage via soluble epoxide hydrolase inhibition.
Wang SB; Pang XB; Zhao Y; Wang YH; Zhang L; Yang XY; Fang LH; Du GH
J Asian Nat Prod Res; 2012; 14(11):1084-92. PubMed ID: 23106500
[TBL] [Abstract][Full Text] [Related]
28. Arg287Gln variant of EPHX2 and epoxyeicosatrienoic acids are associated with insulin sensitivity in humans.
Ramirez CE; Shuey MM; Milne GL; Gilbert K; Hui N; Yu C; Luther JM; Brown NJ
Prostaglandins Other Lipid Mediat; 2014 Oct; 113-115():38-44. PubMed ID: 25173047
[TBL] [Abstract][Full Text] [Related]
29. Association between the EPHX2 p.Lys55Arg polymorphism and prognosis following an acute coronary syndrome.
Oni-Orisan A; Cresci S; Jones PG; Theken KN; Spertus JA; Lee CR
Prostaglandins Other Lipid Mediat; 2018 Sep; 138():15-22. PubMed ID: 30096423
[TBL] [Abstract][Full Text] [Related]
30. Opposite effects of gene deficiency and pharmacological inhibition of soluble epoxide hydrolase on cardiac fibrosis.
Li L; Li N; Pang W; Zhang X; Hammock BD; Ai D; Zhu Y
PLoS One; 2014; 9(4):e94092. PubMed ID: 24718617
[TBL] [Abstract][Full Text] [Related]
31. Soluble epoxide hydrolase contamination of specific catalase preparations inhibits epoxyeicosatrienoic acid vasodilation of rat renal arterioles.
Gauthier KM; Olson L; Harder A; Isbell M; Imig JD; Gutterman DD; Falck JR; Campbell WB
Am J Physiol Renal Physiol; 2011 Oct; 301(4):F765-72. PubMed ID: 21753077
[TBL] [Abstract][Full Text] [Related]
32. Epoxyeicosanoids as mediators of neurogenic vasodilation in cerebral vessels.
Iliff JJ; Wang R; Zeldin DC; Alkayed NJ
Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1352-63. PubMed ID: 19304946
[TBL] [Abstract][Full Text] [Related]
33. Epoxide hydrolase 1 (EPHX1) hydrolyzes epoxyeicosanoids and impairs cardiac recovery after ischemia.
Edin ML; Hamedani BG; Gruzdev A; Graves JP; Lih FB; Arbes SJ; Singh R; Orjuela Leon AC; Bradbury JA; DeGraff LM; Hoopes SL; Arand M; Zeldin DC
J Biol Chem; 2018 Mar; 293(9):3281-3292. PubMed ID: 29298899
[TBL] [Abstract][Full Text] [Related]
34. Pinocembrin protects rats against cerebral ischemic damage through soluble epoxide hydrolase and epoxyeicosatrienoic acids.
Wang SB; Pang XB; Gao M; Fang LH; Du GH
Chin J Nat Med; 2013 May; 11(3):207-13. PubMed ID: 23725831
[TBL] [Abstract][Full Text] [Related]
35. Peroxisomal translocation of soluble epoxide hydrolase protects against ischemic stroke injury.
Nelson JW; Zhang W; Alkayed NJ; Koerner IP
J Cereb Blood Flow Metab; 2015 Sep; 35(9):1416-20. PubMed ID: 26126869
[TBL] [Abstract][Full Text] [Related]
36. Soluble epoxide hydrolase inhibitor trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid is neuroprotective in rat model of ischemic stroke.
Shaik JS; Ahmad M; Li W; Rose ME; Foley LM; Hitchens TK; Graham SH; Hwang SH; Hammock BD; Poloyac SM
Am J Physiol Heart Circ Physiol; 2013 Dec; 305(11):H1605-13. PubMed ID: 24043255
[TBL] [Abstract][Full Text] [Related]
37. A hypothesis-driven study to comprehensively investigate the association between genetic polymorphisms in EPHX2 gene and cardiovascular diseases: Findings from the UK Biobank.
Zhu X; Li Y; Yu T; Li S; Chen M
Gene; 2022 May; 822():146340. PubMed ID: 35183688
[TBL] [Abstract][Full Text] [Related]
38. Down-regulation of EPHX2 gene transcription by Sp1 under high-glucose conditions.
Oguro A; Oida S; Imaoka S
Biochem J; 2015 Sep; 470(3):281-91. PubMed ID: 26341485
[TBL] [Abstract][Full Text] [Related]
39. Change in soluble epoxide hydrolase (sEH) during cisplatin-induced acute renal failure in mice.
Hashimoto T; Fang YI; Ohata H; Honda K
J Toxicol Sci; 2015 Aug; 40(4):451-7. PubMed ID: 26165641
[TBL] [Abstract][Full Text] [Related]
40. Crosstalk between adenosine receptors and CYP450-derived oxylipins in the modulation of cardiovascular, including coronary reactive hyperemic response.
Nayeem MA; Hanif A; Geldenhuys WJ; Agba S
Pharmacol Ther; 2022 Dec; 240():108213. PubMed ID: 35597366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]